McDonald’s is once again serving OmniPork luncheon meat, called ‘vegan Spam’, in its Hong Kong restaurants.
OmniPork's luncheon meat is prepared for soybeans, wheat, and beets. Although coconut oil and salt are still present, they have been reduced in a new formulation.
McDonald's included plant-based choices on its Chinese menu for the first time in late 2020, as part of the morning menu.
It was made available at 280 locations, as well as extra McCafés.
The dish was tested in a few mainland China restaurants.
There were 3.7 million people who bought the original vegan Spam and egg sandwich. Four new breakfast options have been introduced using enhanced OmniPork Luncheon meat. In addition, McDonald's is bolstering its partnership with OmniFoods by including their plant-based fish into several McCafé menu items.
Diners at McDonald's can order Deluxe Breakfasts, Jumbo Breakfasts, McMuffins, and burgers, all of which are made with Omnipork Luncheon meat. On Earth Day, the menu items were revealed. This was a homage to Omnifoods founder David Yeung's Green Monday Group, which is celebrating its tenth anniversary on the same day.


Austal Shares Surge 16% as Hanwha Offers Up to $1.2 Billion for U.S. Shipbuilding Business
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
Singapore Raises 2026 GDP Growth Forecast as AI Demand Fuels Economy
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
CDC Expands Ebola Screening Efforts at U.S. Entry Points Amid Congo and Uganda Outbreak
ADNOC Gas Targets Up to $4B Profit in 2026
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook
Oil Prices Rise as Hormuz Reopening Remains Uncertain
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts
Asian Currencies Steady as Markets Await U.S. Inflation Data
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
Oil Prices Rise as Hormuz Reopening Remains Uncertain
US Dollar Near Two-Month Low as Markets Await Inflation Data
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
US Stock Futures Flat as Iran Strait of Hormuz Demands Fuel Oil Concerns 



